Siemens Healthineers has introduced two new blood-based tau assays for research use on the Atellica platform, expanding its brain health portfolio with tests aimed at advancing neurodegenerative disease research.
The Guardant Hereditary Cancer test is a blood-based genetic screening tool that identifies inherited cancer risk variants.
Virax Biolabs presented data highlighting the role of T-Cell dysfunction, particularly exhaustion markers, in post-acute infection syndromes.
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
The Health Alliance validated a bird flu PCR assay for human diagnostics, a tool for early detection of avian influenza outbreaks.
Having high-quality assays, molecular controls, and automated workflow solutions are critical in...